ROBB GARY CHARLES (Chief Business Officer) reported 3 transactions at CORCEPT THERAPEUTICS INC
Review the transaction codes below to understand the nature of each event.
Filed: 9/28/2026ACC: 0001193125-26-405402
Officer· Chief Business Officer
Since Mar 2026
-7.10K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
10K acquired · 17.10K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−17.10K
Price / share
—
Trade value
—
% of position
54.9%
9/24/2026
31.16K→14.06K
Common Stock
Indirect
Shares
+5K
Price / share
—
Trade value
—
% of position
32.1%
9/24/2026
15.57K→20.57K
Common Stock
Indirect
Shares
+5K
Price / share
—
Trade value
—
% of position
32.1%
9/24/2026
15.57K→20.57K
Total
Net shares
−7.10K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/24/2026 | G · Gift | −17.10K | — | — | 54.9% | 31.16K | 14.06K |
| Common Stock Indirect | 9/24/2026 | G · Gift | +5K | — | — | 32.1% | 15.57K | 20.57K |
| Common Stock Indirect | 9/24/2026 | G · Gift | +5K | — | — | 32.1% | 15.57K | 20.57K |
| Total | −7.10K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned39.72K
Total
39.72K indirect39.72K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 39.72K | Indirect |
| Total | 39.72K | 39.72K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported